Stefan Nilsson
🇸🇪Chief Executive Officer (CEO)/Managing Directory · Lipigon Pharmaceuticals AB
Buys
14
Sells
0
Total bought
€79k
Total sold
€0
Buy Lipigon Pharmaceuticals AB
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
Transaction history
Under EU Market Abuse Regulation Article 19, insiders only disclose trades in their own employer's stock. Other personal investments aren't publicly reported — so a single-ticker history is normal, not a gap in our data.
| Date | Type | Company | Shares | Price | Value | Venue |
|---|---|---|---|---|---|---|
| 2024-12-03 1y ago | BUY | Lipigon Pharmaceuticals AB | 95,164 | €0.02 | €2k | NASDAQ STOCKHOLM AB |
| 2024-12-02 1y ago | BUY | Lipigon Pharmaceuticals AB | 342,315 | €0.01 | €5k | NASDAQ STOCKHOLM AB |
| 2024-09-10 2y ago | BUY | Lipigon Pharmaceuticals AB | 313,425 | €0.02 | €7k | NASDAQ STOCKHOLM AB |
| 2024-06-17 2y ago | BUY | Lipigon Pharmaceuticals AB | 136,056 | €0.02 | €3k | NASDAQ STOCKHOLM AB |
| 2024-04-19 2y ago | BUY | Lipigon Pharmaceuticals AB | 300,852 | €0.03 | €9k | FIRST NORTH SWEDEN |
| 2023-12-20 2y ago | BUY | Lipigon Pharmaceuticals AB | 311,804 | €0.04 | €12k | NASDAQ STOCKHOLM AB |
| 2023-07-20 3y ago | BUY | Lipigon Pharmaceuticals AB | 182,432 | €0.03 | €6k | FIRST NORTH SWEDEN |
| 2023-01-20 3y ago | BUY | Lipigon Pharmaceuticals AB | 40,825 | €0.09 | €4k | NASDAQ STOCKHOLM AB |
| 2022-11-25 3y ago | BUY | Lipigon Pharmaceuticals AB | 37,083 | — | — | NASDAQ STOCKHOLM AB |
| 2022-08-31 4y ago | BUY | Lipigon Pharmaceuticals AB | 35,590 | €0.17 | €6k | NASDAQ STOCKHOLM AB |
| 2022-05-06 4y ago | BUY | Lipigon Pharmaceuticals AB | 42,752 | €0.28 | €12k | NASDAQ STOCKHOLM AB |
| 2022-05-04 4y ago | BUY | Lipigon Pharmaceuticals AB | 6,688 | €0.27 | €2k | NASDAQ STOCKHOLM AB |
| 2022-05-04 4y ago | BUY | Lipigon Pharmaceuticals AB | 32,016 | €0.31 | €10k | NASDAQ STOCKHOLM AB |
| 2022-03-28 4y ago | BUY | Lipigon Pharmaceuticals AB | 4,863 | €0.40 | €2k | NASDAQ STOCKHOLM AB |